Review article · 2026 · Open access

The evolution of iPSC-based cell therapy across autologous and allogeneic pathways

Anmin Wang, Yunpei Zhang, Hongkui Deng, Mingxia Gu

Cell Reports Medicine, 7(10), 102992 · Published 18 August 2026 · DOI 10.1016/j.xcrm.2026.102992

Open full textCite this paper

In brief

“The evolution of iPSC-based cell therapy across autologous and allogeneic pathways” is a 2026 review article by Anmin Wang and 3 co-authors, published in Cell Reports Medicine. OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Cell Reports Medicine.

Citations
0
References
128
Authors
4

Abstract

Induced pluripotent stem cell (iPSC)-based treatments have revolutionized regenerative medicine, yielding patient-specific renewable cells without raising ethical concerns related to the use of embryonic stem cells. In two decades, iPSC therapies have advanced from basic research to clinical trials and official approvals. Early research focused on autologous transplantation, exemplified by the 2014 retinal pigment epithelium (RPE) graft. Yet, personalized production obstacles prompted allogeneic schemes relying on HLA cell banks and immunomodified donor cells. Meanwhile, innovations such as chemical reprogramming have revitalized autologous strategies. Today, autologous and allogeneic iPSC therapies complement each other for distinct clinical demands. This review traces key field milestones and analyzes prospects and hurdles for next-generation iPSC therapies.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wang, A., Zhang, Y., Deng, H., & Gu, M. (2026). The evolution of iPSC-based cell therapy across autologous and allogeneic pathways. Cell Reports Medicine, 7(10), 102992. https://doi.org/10.1016/j.xcrm.2026.102992

MLA 9

Wang, Anmin, et al. “The evolution of iPSC-based cell therapy across autologous and allogeneic pathways.” Cell Reports Medicine, vol. 7, no. 10, 2026, p. 102992. https://doi.org/10.1016/j.xcrm.2026.102992.

Chicago

Wang, Anmin, Yunpei Zhang, Hongkui Deng, and Mingxia Gu. 2026. “The evolution of iPSC-based cell therapy across autologous and allogeneic pathways.” Cell Reports Medicine 7 (10): 102992. https://doi.org/10.1016/j.xcrm.2026.102992.

Harvard

Wang, A. et al. (2026) ‘The evolution of iPSC-based cell therapy across autologous and allogeneic pathways’, Cell Reports Medicine, 7(10), p. 102992. doi:10.1016/j.xcrm.2026.102992.

IEEE

A. Wang, Y. Zhang, H. Deng, and M. Gu, “The evolution of iPSC-based cell therapy across autologous and allogeneic pathways,” Cell Reports Medicine, vol. 7, no. 10, p. 102992, 2026, doi: 10.1016/j.xcrm.2026.102992.

BibTeX

@article{wang2026evolution,
  title     = {{The evolution of iPSC-based cell therapy across autologous and allogeneic pathways}},
  author    = {Wang, Anmin and Zhang, Yunpei and Deng, Hongkui and Gu, Mingxia},
  journal   = {Cell Reports Medicine},
  year      = {2026},
  volume    = {7},
  number    = {10},
  pages     = {102992},
  doi       = {10.1016/j.xcrm.2026.102992},
  url       = {https://doi.org/10.1016/j.xcrm.2026.102992}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research

  • induced pluripotent stem cells
  • autologous transplantation
  • allogeneic transplantation
  • chemical reprogramming
  • clinical translation

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Wang, A., Zhang, Y., Deng, H., & Gu, M. (2026). The evolution of iPSC-based cell therapy across autologous and allogeneic pathways. Cell Reports Medicine, 7(10), 102992. https://doi.org/10.1016/j.xcrm.2026.102992

How many times has this paper been cited?

0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cell Reports Medicine: sign in and open the full text from this page.

Who wrote this paper?

Anmin Wang, Yunpei Zhang, Hongkui Deng, Mingxia Gu.

What is the DOI of this paper?

10.1016/j.xcrm.2026.102992, permanently at https://doi.org/10.1016/j.xcrm.2026.102992. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.